Fund Details
UTI Dual Advantage Fixed Term Fund Series V I (1103 Days) Regular Growth
| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.06% |
| NAV | ₹11.40 (21 Sep 2020) |
|---|---|
| Fund Started | 14 Sep 2017 |
| Fund Size | ₹40 Cr |
Returns
Comparison
Found nothing so far.
Found nothing so far.
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| REC Ltd. | Financial | Bonds | 9.5% |
| Power Finance Corpn. Ltd. | Financial | Bonds | 8.3% |
| LIC Housing Finance Ltd. | Financial | Debenture | 7.5% |
| HDFC Bank Ltd. | Financial | Equity | 1.2% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 1.0% |
| Mphasis Ltd. | Technology | Equity | 1.0% |
| ICICI Bank Ltd. | Financial | Equity | 0.8% |
| Tata Power Co. Ltd. | Energy | Equity | 0.5% |
| Grasim Industries Ltd. | Construction | Equity | 0.4% |
| ITC Ltd. | FMCG | Equity | 0.4% |
Fund Managers
UTI Dual Advantage Fixed Term Fund Series V I (1103 Days) Regular Growth Details
UTI Dual Advantage Fixed Term Fund Series V I (1103 Days) Regular Growth is a Hybrid Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 14 Sep 2017. V Srivatsa, Sunil Patil is the Current Fund Manager of UTI Dual Advantage Fixed Term Fund Series V I (1103 Days) Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹40 Cr and the Latest NAV as of 21 Sep 2020 is ₹11.40.
The UTI Dual Advantage Fixed Term Fund Series V I (1103 Days) Regular Growth is rated Moderately High risk.
Investment Objective
The scheme seeks to generate income and reduce interest rate volatility by investing in fixed income securities that are maturing on or before the date of maturity of the Scheme and generate capital appreciation by investing in equity and equity related instruments.
